why does semaglutide cause depression The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Semaglutide & Mental Health |

A SARMOUNT-5 phase 3b clinical study depicts that tirzepatide reduced body weight by 20.2% of the initial weight

Validated in a randomised controlled trial with T1D patients on automated insulin delivery

However, it was soon removed from the market because of side effects related to the high exposure of the drug to the CNS and brain, which resulted in safety issues such as depression, anxiety and suicidal ideations

Proper timing, dosing, and monitoring are essential for maximizing the benefits of semaglutide

When planning timelines for clinical studies or manufacturing, procurement managers and quality assurance teams need to keep these safety features in mind

But well get to the point where there are a lot of different options on the market, and then its going to be up to which one has the most catchy drug pitch, advertisement, or name. The success of GLP-1 drugs may also influence future drug development trends